Efficacy of venadaparib plus irinotecan in homologous recombination deficiency (HRD) gene mutations as 3+ line treatment in patients with metastatic gastric cancer (mGC).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Won Sik Lee, Kyoung Soo Ha, Jeongsook Bang, Minju Hong, Myongjae Lee, Eun-Jihn Roh, Chan-Young Ock
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410814839